I-MAK’s team has spent the last decade increasing transparency on patents, innovation, and access.

Amicus Brief Filed in Oil States vs. Greene Energy Group Supreme Court Case: The Critical Role of Patent Challenges in Increasing Competition and Reducing Drug Prices

In 2011, Congress passed the Leahy-Smith America Invents Act (“AIA”) to curb the spread of unmerited patents, stop abusive litigation, and ensure a fair playing field for patent applicants. Leahy-Smith America Invents Act, Pub. L. No. 112- 20, 125 Stat. 284, 35 U.S.C. § 1 et seq. (2011). In the face of industry overreliance on…

Briefs & Fact Sheets 30 Oct 2017

FDA Submission for Administering The Hatch-Waxman Amendments: Ensuring A Balance Between Innovation And Access

“Administering the Hatch-Waxman Amendments: Ensuring a Balance Between Innovation and Access” was a meeting held on July 18, 2017 to provide the public an opportunity to submit comments concerning administration of the Hatch-Waxman Amendments to the Federal Food, Drug, and Cosmetic Act (FD&C Act) to help ensure the intended balance between encouraging innovation in drug…

Commentaries 17 Sep 2017

Partner with us now to build
a more just and equitable
medicine system for all.